A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocol

BACKGROUND: The U.S. Food and Drug Administration can set standards for cigarettes that could include reducing their nicotine content. Such a standard should improve public health without causing unintended serious consequences for sub-populations. This study evaluates the effect of progressive nico...

Descripción completa

Detalles Bibliográficos
Autores principales: Allen, Sophia I., Foulds, Jonathan, Pachas, Gladys N., Veldheer, Susan, Cather, Corinne, Azzouz, Nour, Hrabovsky, Shari, Hameed, Ahmad, Yingst, Jessica, Hammett, Erin, Modesto, Jennifer, Krebs, Nicolle M., Zhu, Junjia, Liao, Jason, Muscat, Joshua E., Richie, John, Evins, A. Eden
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5248523/
https://www.ncbi.nlm.nih.gov/pubmed/28103841
http://dx.doi.org/10.1186/s12889-016-3946-4

Ejemplares similares

Ejemplares similares